Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia

Bibliographic Data

ID15713474
AuthorsLouise Tofts (0000-0002-3961-0493, Macquarie University, corresponding author), Penny Ireland (The University of Queensland), Tracy Tate (Children's Hospital at Westmead), Supriya Raj (Murdoch Children's Research Institute), Theresa L Carroll (Queensland Children’s Hospital), Theresa Carroll (Queensland Children’s Hospital, South Brisbane, QLD 4101, Australia), Craig F Munns (0000-0001-5898-5808, The University of Queensland), Stephen Knipe (The Newcastle Paediatric Clinic, New Lambton Heights, NSW 2305, Australia), Katherine Langdon (0000-0001-9729-6984, The Kids Research Institute Australia), Lesley Mcgregor (0000-0002-7093-1391, Women's and Children's Hospital), F Ellis McKenzie (0000-0003-4853-5269, The University of Western Australia), Andreas Zankl (0000-0001-8612-1062, The University of Sydney), Ravi Savarirayan (0000-0002-5105-8427, Royal Children's Hospital)
Year2024
Volume11
Issue7
Pages789-789
Publication date2024-06-28
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children11070789
PMID39062238
OpenAlexW4400120268
LanguageEN
References cited19

These recommendations have been developed for healthcare professionals and institutions that are engaged in using vosoritide in the management of achondroplasia and will be revised using a formal framework for clinical guideline development once more evidence is available

Achondroplasia · Connective tissue disorders research · Medicine · Pancreatic and Hepatic Oncology Research · Pancreatitis Pathology and Treatment · Psychology · Pediatrics

Tools

Open DOIOpen Access